Researchers at the Institute of Pathology at University Medical Center Göttingen (UMG), Germany, have developed and filed a patent for a new device that significantly facilitates the isolation of ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data evaluating DecisionDx-Melanoma’s i31-SLNB test ...